Observational Study of Patients with Polycythemia Vera in U.S. Clinical Practices (REVEAL)

Purpose

To describe the clinical burden, healthcare resource utilization, complications, practice patterns, and therapy strategies in patients treated for PV in academic & community clinical practices within the United States.

Criteria

Patients 18 years of age or older

Diagnosis of PV Currently receiving care for PV by a physician

Willing & able to complete patient assessment questionnaires

Not diagnosed with myelofibrosis (MF), secondary Acute Myeloid Leukemia (AML), or Myelodysplastic Syndrome (MDS)

Has not had a stem cell transplant or splenectomy

Details

Data will be collected at Enrollment & at usual care visits, assumed to be approximately every 3-6 Months

Quality of life questionnaires will be completed at Enrollment & at 3-month intervals

Optional blood sample collected at Enrollment & annually for genetic mutation analysis

Interested in more information? Contact Us:

Hematology Oncology Associates

IRB: Sterling
IRB Number:
Trial Type: Drug
Sponsor: Incyte Corp